CA3223905A1 - Method to control administration of active substance to the digestive tract - Google Patents
Method to control administration of active substance to the digestive tract Download PDFInfo
- Publication number
- CA3223905A1 CA3223905A1 CA3223905A CA3223905A CA3223905A1 CA 3223905 A1 CA3223905 A1 CA 3223905A1 CA 3223905 A CA3223905 A CA 3223905A CA 3223905 A CA3223905 A CA 3223905A CA 3223905 A1 CA3223905 A1 CA 3223905A1
- Authority
- CA
- Canada
- Prior art keywords
- capsule
- hpmc
- sample
- active substance
- capsules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163214438P | 2021-06-24 | 2021-06-24 | |
| US63/214,438 | 2021-06-24 | ||
| PCT/US2022/034683 WO2022271922A1 (en) | 2021-06-24 | 2022-06-23 | Method to control administration of active substance to the digestive tract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3223905A1 true CA3223905A1 (en) | 2022-12-29 |
Family
ID=84544830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3223905A Pending CA3223905A1 (en) | 2021-06-24 | 2022-06-23 | Method to control administration of active substance to the digestive tract |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240285699A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4340819A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024526149A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117479929A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022299196A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023027371A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3223905A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022271922A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116270523B (zh) * | 2023-05-15 | 2023-08-08 | 四川厌氧生物科技有限责任公司 | 一种耐酸的口服双层胶囊及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2667167C (en) * | 2006-10-27 | 2014-02-18 | Pfizer Products Inc. | Hydroxypropyl methyl cellulose hard capsules and process of manufacture |
| BR112012006651B1 (pt) * | 2009-09-24 | 2021-11-03 | Capsugel Belgium Nv | Cápsula farmacêutica dura resistente a ácido e composição aquosa compreendendo goma de gelano e hpmc |
| DE102010022174A1 (de) * | 2010-05-12 | 2011-11-17 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Neue Darreichungsformen für Cineol |
| US9907755B2 (en) * | 2013-03-14 | 2018-03-06 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
| EP3028694B1 (en) * | 2014-12-02 | 2017-07-12 | Capsugel Belgium NV | Dosage form articles for delayed release |
| EP3882259B1 (en) * | 2015-05-13 | 2026-01-28 | Synlogic Operating Company, Inc. | Bacteria engineered to reduce hyperphenylalaninemia |
| EP4480495A3 (en) * | 2017-07-10 | 2025-06-18 | Gel Cap Technologies, LLC | Dual release dosage form capsule and methods, devices and systems for making same |
| US20190388344A1 (en) * | 2018-06-22 | 2019-12-26 | Probiotech Llc | Method to Improve The Health Of The Microbiome In A Human Gastrointestinal System and Multi-Chamber Probiotic Delivery Products Therefor |
| US20200038215A1 (en) * | 2018-08-01 | 2020-02-06 | Ethicon, Inc. | Transient implantable device to control absorption of nutrients |
| US12144834B2 (en) * | 2018-09-13 | 2024-11-19 | Xbiome Inc. | Methods and compositions for treating gastrointestinal and inflammatory disorders |
| CA3117956A1 (en) * | 2018-10-30 | 2020-05-07 | Vitabolus Inc. | Oral delivery of therapeutic mammalian cells |
| MX2022004515A (es) * | 2019-10-16 | 2022-07-12 | Capsugel Belgium Nv | Metodo y composicion para aumentar la sintesis de proteinas musculares. |
-
2022
- 2022-06-23 US US18/572,983 patent/US20240285699A1/en active Pending
- 2022-06-23 CN CN202280041826.5A patent/CN117479929A/zh active Pending
- 2022-06-23 CA CA3223905A patent/CA3223905A1/en active Pending
- 2022-06-23 WO PCT/US2022/034683 patent/WO2022271922A1/en not_active Ceased
- 2022-06-23 AU AU2022299196A patent/AU2022299196A1/en active Pending
- 2022-06-23 BR BR112023027371A patent/BR112023027371A2/pt unknown
- 2022-06-23 EP EP22829292.6A patent/EP4340819A4/en active Pending
- 2022-06-23 JP JP2023578776A patent/JP2024526149A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022299196A1 (en) | 2023-12-21 |
| BR112023027371A2 (pt) | 2024-03-12 |
| JP2024526149A (ja) | 2024-07-17 |
| CN117479929A (zh) | 2024-01-30 |
| EP4340819A4 (en) | 2025-04-02 |
| WO2022271922A1 (en) | 2022-12-29 |
| EP4340819A1 (en) | 2024-03-27 |
| US20240285699A1 (en) | 2024-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10874619B2 (en) | Acid resistant capsules | |
| JP6860596B2 (ja) | プロバイオティクス生物及び/又は治療剤の標的化胃腸管デリバリー | |
| US7122370B2 (en) | Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life | |
| Xing et al. | Oral colon-specific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome | |
| JP3752421B2 (ja) | 乳酸菌の安定化のための微細腸溶性コーティング顆粒 | |
| TWI584824B (zh) | A capsule for delivery to a large intestine and a method of manufacturing the same | |
| Marzorati et al. | Comparison of protection and release behavior of different capsule polymer combinations based on L. acidophilus survivability and function and caffeine release | |
| Drechsler et al. | Development and evaluation of chitosan and chitosan/Kollicoat® Smartseal 30 D film-coated tablets for colon targeting | |
| US20240285699A1 (en) | Method to Control Administration of Active Substance to the Digestive Tract | |
| KR102483912B1 (ko) | 연질캡슐형 건강기능식품의 제조방법 | |
| JP5957280B2 (ja) | 大腸デリバリーシームレスカプセル製剤及びその製造方法 | |
| JP5907796B2 (ja) | 腸内環境改善食品 | |
| JP2004250338A (ja) | 有用生菌製剤 | |
| US9750815B2 (en) | Composition comprising shellac and/or a salt thereof and sodium starch glycolate | |
| CN117257845A (zh) | 靶向投递活益生菌的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250610 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250610 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260609 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260609 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20260623 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT Effective date: 20260623 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260623 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260724 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20260724 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20260724 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20260724 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260724 Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260724 |